Artigos de Revisão
Study Coordination and its key role in Clinical Research
Conteúdo principal do artigo
Inês Zimbarra Cabrita
Francisca Patuleia Figueiras
Margarida Nogueira
Susana Silva
Cecília Gomes
Fausto J. Pinto
Resumo
Há cada vez mais literatura sobre o benefício das Instituições de Saúde em investirem em Investigação Clínica (IC) – os outcomes clínicos parecem ser melhores, a integração das diretrizes mais eficaz e consequentemente, vemos uma melhoria na prestação de cuidados de saúde ao doente. A existência de Unidades de Apoio à Investigação Clínica (UAIC) torna-se essencial, dando suporte nas tarefas que exigem tempo e expertise e garantindo a segurança do doente e a qualidade dos dados. A integração de um Coordenador de Investigação Clínica (CIC) numa equipa de investigação parece trazer inúmeras vantagens, pois o mesmo poderá ficar responsável por uma boa parte das atividades de IC.
Esta revisão narrativa complementa a literatura atual sobre o papel que uma UAIC e um CIC têm na Investigação Clínica, bem como os benefícios que estes trazem.
Uma UAIC sólida dá origem a investigação eficiente e de qualidade, o que, por sua vez, leva à melhoria e otimização da prestação de cuidados de saúde, dos outcomes e das infraestruturas, bem como à criação de postos de trabalho e redução de custos.
A presença de uma UAIC em conjunto com uma equipa especializada de CICs não só facilita a condução de estudos promovidos pela Indústria, mas também permite o desenvolvimento de Estudos da Iniciativa do Investigador.
Torna-se evidente a necessidade de serem desenvolvidos mais estudos em Portugal sobre o impacto clínico e socioeconómico da Investigação Clínica de excelência.
Detalhes do artigo
Este trabalho encontra-se publicado com a Creative Commons Atribuição-NãoComercial 4.0.
Referências
Bois A du, Rochon J, Lamparter C, PFisterer J. Pattern of care and impact of participation in clinical studies on the outcome in ovarian cancer. Int J GynecolCancer. 2005;15:183-91. doi:10.1111/j.1525-1438.2005.15202.x
Majumdar SR. Better Outcomes for Patients Treated at Hospitals That Participate in Clinical Trials. Arch Intern Med. 2008;168:657. doi:10.1001/archinternmed.2007.124
Downing A, Morris EJ, Corrigan N, Sebag-Montefiore D, Finan PJ, Thomas JD,
et al. High hospital research participation and improved colorectal cancer survival outcomes: a population-based study. Gut. 2017;66:89-96. doi:10.1136/gutjnl-2015-311308
Nijjar S, D’Amico M, Wimalaweera N, Cooper N, Zamora J, Khan K. Participation in clinical trials improves outcomes in women’s health: a systematic review and meta-analysis. BJOG. 2017;124:863-71. doi:10.1111/1471-0528.14528
Karjalainen S, Palva I. Do treatment protocols improve end results? A study of survival of patients with multiple myeloma in Finland. BMJ. 1989;299:1069-72. doi:10.1136/bmj.299.6707.1069
Clarke M, Loudon K. Effects on patients of their healthcare practitioner’s or institution’s participation in clinical trials: a systematic review. Trials. 2011;12:16. doi:10.1186/1745-6215-12-16
Rochon J, du Bois A, Lange T. Mediation analysis of the relationship between institutional research activity and patient survival. BMC Med Res Methodol. 2014;14:9. doi:10.1186/1471-2288-14-9
Seruga B, Sadikov A, Cazap EL, Delgado LB, Digumarti R, Leighl NB,
et al. Barriers and Challenges to Global Clinical Cancer Research. Oncologist. 2014;19:61-7. doi:10.1634/theoncologist.2013-0290
Ross S, Grant A, Counsell C, Gillespie W, Russell I, Prescott R. Barriers to Participation in Randomised Controlled Trials. J Clin Epidemiol. 1999;52:1143-56. doi:10.1016/S0895-4356(99)00141-9
Sumi E, Murayama T, Yokode M. A survey of attitudes toward clinical research among physicians at Kyoto University Hospital. BMC Med Educ. 2009;9:75. doi:10.1186/1472-6920-9-75
Chen DT. Clinical Research and the Physician–Patient Relationship. Ann Intern Med. 2003;138:669. doi:10.7326/0003-4819-138-8-200304150-00015
Dev AT, Kauf TL, Zekry A, Patel K, Heller K, Schulman KA,
et al. Factors influencing the participation of gastroenterologists and hepatologists in clinical research. BMC Health Services Research. 2008;8:208. doi:10.1186/1472-6963-8-208
Yanagawa H, Kishuku M, Akaike M, Azuma H, Irahara M. View of physicians on and barriers to patient enrollment in a multicenter clinical trial: experience in a Japanese rural area. Int Arch Med. 2010;3:7. doi:10.1186/1755-7682-3-7
Albers LL, Sedler KD. Clinician perspectives on participation in research. J Midwifery Womens Health. 2004;49:47-50. doi: 10.1016/j.jmwh.2003.09.013.
Gawlinski A. The Power of Clinical Nursing Research: Engage Clinicians, Improve Patients’ Lives, and Forge a Professional Legacy. Am J Critical Care. 2008;17:315-26. doi:10.4037/ajcc2008.17.4.315
Yanos PT, Ziedonis DM. The Patient-Oriented Clinician-Researcher: Advantages and Challenges of Being a Double Agent. Psychiatric Serv. 2006;57:249-53. doi:10.1176/appi.ps.57.2.249
Albers LL, Sedler KD. Clinician perspectives on participation in research. J Midwifery Womens Health. 2004;49:47-50. doi: 10.1016/j.jmwh.2003.09.013.
Taylor KM. Integrating conflicting professional roles: Physician participation in randomized clinical trials. Soc Sci Med. 1992;35:217-24. doi:10.1016/0277-9536(92)90169-Q
Rahman S, Majumder MA, Shaban SF, Rahman N, Ahmed M, Abdulrahman KB, et al. Physician participation in clinical research and trials: issues and approaches. Adv Med Educ Pract. 2011;2:85-93. doi: 10.2147/AMEP.S14103.
Rubio DM, Primack BA, Switzer GE, Bryce CL, Seltzer DL, Kapoor WN. A Comprehensive Career-Success Model for Physician–Scientists. Acad Med. 2011;86:1571-6. doi:10.1097/ACM.0b013e31823592fd
Croghan IT, Viker SD, Limper AH, Evans TK, Cornell AR, Ebbert JO, et al. Developing a clinical trial unit to advance research in an academic institution. Contemp Clin Trials. 2015;45:270-6. doi: 10.1016/j.cct.2015.10.001.
Cimino J, Braun C. Building a competitive infrastructure to support clinical research in healthcare institution. Eur J Clin Invest. 2021;51(9). doi:10.1111/eci.13641
Divate U, Divate P, Bhosale N, Das S. Best practices sharing: Setting up a professional clinical research unit in India. Perspect Clin Res. 2014;5:37. doi:10.4103/2229-3485.124570
Pelke S, Easa D. The Role of the Clinical Research Coordinator in Multicenter Clinical Trials. J ObstetGynecolNeonatal Nurs. 1997;26:279-85. doi:10.1111/j.1552-6909.1997.tb02143.x
Annahern J, Kruger DF, Gatcomb PM, Petit WA, Tamborlane WV. The Diabetes Control and Complications Trial (DCCT): The Trial Coordinator Perspective. Diabetes Educ. 1989;15:236-41. doi:10.1177/014572178901500313
Mullin SM, Warwick S, Akers M, Beecher P, Helminger K, Moses B, et al. An acute intervention trial: the research nurse coordinator's role. Control Clin Trials. 1984;5:141-56. doi: 10.1016/0197-2456(84)90120-x.
Ahern J, Grove N, Strand T, Wesche J, Seibert C, Brenneman AT, et al. The impact of the Trial Coordinator in the Diabetes Control and Complications Trial (DCCT). The DCCT Research Group. Diabetes Educ. 1993;19:509-12. doi: 10.1177/014572179301900606.
World Medical Association Declaration of Helsinki. JAMA. 2013;310:2191. doi:10.1001/jama.2013.281053
Larkin ME, Lorenzi GM, Bayless M, Cleary PA, Barnie A, Golden E, et al. Evolution of the study coordinator role: the 28-year experience in Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC). Clin Trials. 2012;9:418-25. doi: 10.1177/1740774512449532.
European Medicines Agency. Guideline on the Content, Management and Archiving of the Clinical Trial Master File. 2017.[accessed Dez 2021] Available from:http://www.ema.europa.eu/
International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) ICH Harmonised Guideline Integrated Addendum to ICH E6(R1): guideline for good clinical practice E6(R2). London: ICH; 2016.
European Medicines Agency. Audit Checklist Interpretation Guide. [accessed Dez 2021] Available from:http://www.ema.europa.eu
Bentley C, Cressman S, van der Hoek K, Arts K, Dancey J, Peacock S. Conducting clinical trials—costs, impacts, and the value of clinical trials networks: A scoping review. Clin Trials. 2019;16:183-93. doi:10.1177/1740774518820060
Konwar M, Bose D, Gogtay NJ, Thatte UM. Investigator-initiated studies: Challenges and solutions. Perspect Clin Res. 9:179-83. doi:10.4103/picr.PICR_106_18
Selby P, Kaplan R, Cameron D, Cooper M, Seymour M. The Royal College of Physicians Simms Lecture, 6 December 2011: Clinical research networks and the benefits of intensive healthcare systems. Clin Med. 2012;12:446-52. doi:10.7861/clinmedicine.12-5-446
Janni W, Kiechle M, Sommer H, Rack B, Gauger K, Heinrigs M, et al; ADEBAR Study Group. Study participation improves treatment strategies and individual patient care in participating centers. Anticancer Res. 2006;26:3661-7.
van Gijn W, Krijnen P, Lemmens VE, den Dulk M, Putter H, van de Velde CJ. Quality assurance in rectal cancer treatment in the Netherlands: A catch up compared to colon cancer treatment. Eur J Surg Oncol. 2010;36:340-4. doi:10.1016/j.ejso.2009.10.010
Krzyzanowska MK, Kaplan R, Sullivan R. How may clinical research improve healthcare outcomes? Ann Oncol. 2011;22:vii10-vii15. doi:10.1093/annonc/mdr420
KPMG. Impact and Value of the NIHR Clinical Research Network - Financial Years 2016/17-2018/19. Amstelveen: KPMG; 2019.
Rocha C, Serras R. Ensaios Clínicos em Portugal. Lisboa: Apifarma; 2019.
